Editorial: Novel therapeutic approaches for biliary tract cancer and hepatocellular carcinoma
出版年份 2023 全文链接
标题
Editorial: Novel therapeutic approaches for biliary tract cancer and hepatocellular carcinoma
作者
关键词
-
出版物
Frontiers in Cell and Developmental Biology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2023-11-03
DOI
10.3389/fcell.2023.1320084
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Evaluation of Tazemetostat as a Therapeutically Relevant Substance in Biliary Tract Cancer
- (2023) Dino Bekric et al. Cancers
- Hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Disease Primers
- Conditional Recurrence-Free Survival after Oncologic Extended Resection for Gallbladder Cancer: An International Multicenter Analysis
- (2021) Eduardo A. Vega et al. ANNALS OF SURGICAL ONCOLOGY
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Immunmodulatory Treatment Strategies of Hepatocellular Carcinoma: From Checkpoint Inhibitors Now to an Integrated Approach in the Future
- (2021) Matthias Ocker et al. Cancers
- HDAC Screening Identifies the HDAC Class I Inhibitor Romidepsin as a Promising Epigenetic Drug for Biliary Tract Cancer
- (2021) Christian Mayr et al. Cancers
- Epidemiology of Hepatocellular Carcinoma
- (2020) Katherine A. McGlynn et al. HEPATOLOGY
- Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets
- (2019) Daniel Neureiter et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis
- (2019) Florian Moik et al. Scientific Reports
- Meta-analysis of prognostic factors for overall survival in patients with resected hilar cholangiocarcinoma
- (2018) N. T. E. Bird et al. BRITISH JOURNAL OF SURGERY
- Sorafenib: A Review in Hepatocellular Carcinoma
- (2017) Gillian M. Keating Targeted Oncology
- Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium
- (2016) Georgios Antonios Margonis et al. HPB
- Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinoma
- (2015) Jiang Chen et al. CANCER LETTERS
- Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection
- (2015) Bas Groot Koerkamp et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
- (2015) Jordi Bruix et al. LANCET ONCOLOGY
- The role of polycomb repressive complexes in biliary tract cancer
- (2014) Christian Mayr et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma
- (2014) Michael N. Mavros et al. JAMA Surgery
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- (2010) Juan Valle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current Management of Gallbladder Carcinoma
- (2010) A. X. Zhu et al. ONCOLOGIST
- Microvessel density correlates with lymph node metastases and prognosis in hilar cholangiocarcinoma
- (2008) Armin Thelen et al. JOURNAL OF GASTROENTEROLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started